Common adverse effects include gastrointestinal symptoms such as nausea, vomiting, diarrhea, and constipation, which typically diminish over time
Tirzepatide and retatrutide are also glucose-dependent insulinotropic polypeptide (GIP) agonists
The coverage pool is finite
Answer: An accidentally high dose is not life-threatening, but you will likely experience severe side effects (extreme nausea, stomach distress) 2 to 4 hours later
Please refrain from any form of ingestion
Chemical Formula: CHNO Molecular Weight: 4845.444 g/mol CAS Number: 2381089-83-2 Purity: typically 9599%, verified through analytical testing Supplied as 60 mg lyophilized peptide in sealed vials Structural modifications: fatty acid conjugation and C-terminal amidation Intended for laboratory investigation of metabolic signaling pathways For research use only How is Retatrutide (60 mg) synthesized